We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients (PREST)

This study has been terminated.
(Inclusion curve too slow.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01321866
First Posted: March 24, 2011
Last Update Posted: June 3, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nīmes
  Purpose
The main objective of this study is to evaluate and compare the primary patency rate at 12 months in a group of hemodialysis patients operated on by cutting balloon and in a group of hemodialysis patients operated by conventional balloon.

Condition Intervention
Arteriovenous Fistula Fistula Procedure: Cutting balloon angioplasty Procedure: Angioplasty

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Trial Comparing a Cutting Balloon to a Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients

Resource links provided by NLM:


Further study details as provided by Centre Hospitalier Universitaire de Nīmes:

Primary Outcome Measures:
  • Primary patency [ Time Frame: 12 months ]
    Primary patency following a first angioplasty of a first stenose in the affected zone.


Secondary Outcome Measures:
  • Number of early re-stenoses [ Time Frame: 3 months ]
    stenosis defined as lumen diameter < 2mm

  • Number of re-stenoses [ Time Frame: 12 months ]
    Stenosis defined as lumen diameter < 2mm

  • Total days in hospital [ Time Frame: 12 months ]
    The total number of days hospitalized for stenosis, thrombosis, or recovering vascular access. This does not include regular hemodialysis activities.

  • Number of stents used [ Time Frame: 12 months ]
    The total number of stents placed between the study angioplasty and the end-of-study visit.

  • Total number of venous thromboses [ Time Frame: 12 months ]
    Total number of venous thromboses between study angioplasty and end-of-study visit

  • Direct medical costs (€) [ Time Frame: 12 months ]
  • Indirect costs (€) [ Time Frame: 12 months ]
  • Questionnaire KDQOL [ Time Frame: 12 months ]
  • Questionnaire SF36 [ Time Frame: 12 months ]
  • Questionnaire KDQOL [ Time Frame: 3 months ]
  • Questionnaire KDQOL [ Time Frame: 6 months ]
  • Questionnaire SF36 [ Time Frame: 3 months ]
  • Questionnaire SF36 [ Time Frame: 6 months ]
  • Fistula quality (cm*ml/min) [ Time Frame: Baseline ]
    cumulative length of "usable" fistula (cm) * venous flow during the last hemodialysis (ml/min)

  • Fistula quality (cm*ml/min) [ Time Frame: 6 months ]
    cumulative length of "usable" fistula (cm) * venous flow during the last hemodialysis (ml/min)

  • Fistula quality (cm*ml/min) [ Time Frame: 12 months ]
    cumulative length of "usable" fistula (cm) * venous flow during the last hemodialysis (ml/min)

  • % Stenosis [ Time Frame: Baseline ]
    100-((the smallest diameter of the stenosis lumen (mm)/ the diameter of a proximal, normal portion of lumen (mm))*100)

  • % Stenosis [ Time Frame: 6 months ]
    100-((the smallest diameter of the stenosis lumen (mm)/ the diameter of a proximal, normal portion of lumen (mm))*100)

  • % Stenosis [ Time Frame: 12 months ]
    100-((the smallest diameter of the stenosis lumen (mm)/ the diameter of a proximal, normal portion of lumen (mm))*100)

  • Presence/absence of complications associated with the angioplasty [ Time Frame: Day of intervention ]
  • % Stenosis [ Time Frame: 3 months ]
    100-((the smallest diameter of the stenosis lumen (mm)/ the diameter of a proximal, normal portion of lumen (mm))*100)

  • Presence/absence of complications since the last visit [ Time Frame: 6 months ]
  • Presence/absence of complications since the last visit [ Time Frame: 12 months ]

Enrollment: 42
Study Start Date: May 2012
Study Completion Date: December 2015
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Experimental arm
Patients in this arm will have angioplasty of a fistula stenosis using a cutting balloon
Procedure: Cutting balloon angioplasty
Angioplasty of fistula stenosis using a cutting balloon
Active Comparator: Standard arm
Patients in this arm will have angioplasty of a fistula stenosis using a non-cutting balloon.
Procedure: Angioplasty
Angioplasty of fistula stenosis using a non-cutting balloon

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up
  • The patient is on hemodialysis because of chronic renal insufficiency
  • The patient's vascular access is an arterio-venous fistula
  • The patient has a venous stenosis in the fistula (first event in the studied zone)
  • The patient is scheduled for angioplasty

Exclusion Criteria:

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient cannot fluently read French
  • The patient cannot understand French
  • The patient is pregnant
  • The patient is breastfeeding
  • Short term dialysis
  • The vascular access is a "graft"
  • The stenosis in question is a recurrence, and not a first event in the studied zone
  • The life expectancy of the patient is < 12 months
  • Medical emergency situation
  • Peritoneal dialysis
  • At-home dialysis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01321866


Locations
France
Centre Hospitalier Universitaire de Nîmes
Nîmes Cedex 09, Gard, France, 30029
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nīmes
Investigators
Principal Investigator: Eric Picard, MD Centre Hospitalier Universitaire de Nîmes
  More Information

Responsible Party: Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier: NCT01321866     History of Changes
Other Study ID Numbers: AOI/2010/EP-01
2011-A00332-39 ( Other Identifier: RCB number )
First Submitted: March 23, 2011
First Posted: March 24, 2011
Last Update Posted: June 3, 2016
Last Verified: June 2016

Keywords provided by Centre Hospitalier Universitaire de Nīmes:
Angioplasty
cutting balloon

Additional relevant MeSH terms:
Fistula
Arteriovenous Fistula
Pathological Conditions, Anatomical
Arteriovenous Malformations
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Fistula
Vascular Diseases
Congenital Abnormalities